Medicenna Therapeutics Corp.
MDNAF
$0.56
$0.012.01%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.59% | -16.13% | -34.01% | 108.02% | -1.37% |
| Total Depreciation and Amortization | -10.85% | 106.17% | 270.27% | 1,785.71% | 1,742.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -174.70% | 113.60% | -94.50% | -168.13% | 351.67% |
| Change in Net Operating Assets | -65.60% | 89.33% | 40.86% | 210.05% | -26.90% |
| Cash from Operations | -40.23% | 12.90% | -50.64% | 3.13% | 14.18% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -100.00% | -99.75% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -101.00% | -102.67% | -99.82% | -- | -- |
| Foreign Exchange rate Adjustments | -112.54% | 182.51% | -889.84% | -295.90% | 1,119.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,098.76% | 10.34% | -123.22% | -1.47% | 89.36% |